1. 2021
  2. Цитокиновый шторм при COVID-19

    Анисенкова, А. Ю., Вологжанин, Д. А., Голота, А. С., Камилова, Т. А., Макаренко, С. В., Мосенко, С. В. & Щербак, С. Г., 2021, In: Профилактическая и клиническая медицина. 1(780, p. 89-95

    Research output: Contribution to journalLiterature reviewpeer-review

  3. Цитокиновый шторм при COVID-19 (научный обзор)

    Анисенкова, А. Ю., Вологжанин, Д. А., Голота, А. С., КАМИЛОВА, ТАТЬЯНА. АСКАРОВНА., Макаренко, С. В., Мосенко, С. В. & Щербак, С. Г., 2021, In: Профилактическая и клиническая медицина. 1(78), p. 89-96 7 p.

    Research output: Contribution to journalArticlepeer-review

  4. 2020
  5. Understanding complex dynamics of behavioral, neurochemical and transcriptomic changes induced by prolonged chronic unpredictable stress in zebrafish

    Demin, K. A., Lakstygal, A. M., Krotova, N. A., Masharsky, A., Tagawa, N., Chernysh, M. V., Ilyin, N. P., Taranov, A. S., Galstyan, D. S., Derzhavina, K. A., Levchenko, N. A., Kolesnikova, T. O., Mor, M. S., Vasyutina, M. L., Efimova, E. V., Katolikova, N., Prjibelski, A. D., Gainetdinov, R. R., de Abreu, M. S., Amstislavskaya, T. G. & 2 others, Strekalova, T. & Kalueff, A. V., Dec 2020, In: Scientific Reports. 10, 1, 19981.

    Research output: Contribution to journalArticlepeer-review

  6. Trace amine-associated receptor 2: brain expression and it's role in neurochemistry and behaviour

    Куварзин, С. Р., Ефимова, Е. В., Католикова, Н. В., Мор, М. С., Козлова, А. А. & Гайнетдинов, Р. Р., 17 Nov 2020, In: European Neuropsychopharmacology. 40, Supplement 1, p. S41-S42 2 p., P.063.

    Research output: Contribution to journalConference articlepeer-review

  7. Enhanced dopamine transmission and hyperactivity in the dopamine transporter heterozygous mice lacking the D3 dopamine receptor

    Sotnikova, T. D., Efimova, E. V. & Gainetdinov, R. R., 3 Nov 2020, In: International Journal of Molecular Sciences. 21, 21, 11 p., 8216.

    Research output: Contribution to journalArticlepeer-review

  8. Cell Replacement Therapy in Parkinson’s Disease—History of Development and Prospects for Use in Clinical Practice

    Katolikova, N. V., Malashicheva, A. B. & Gainetdinov, R. R., Nov 2020, In: Molecular Biology. 54, 6, p. 827-839 13 p.

    Research output: Contribution to journalReview articlepeer-review

  9. Intracerebroventricular injection of the cardiotonic steroid digoxin, but not bufalin, causes mania-like behavior in C57Black/6 mice

    Timoshina, Y., Lopachev, A. V., Volnova, A. B., Kazanskaya, R. B., Fedorova, T. N. & Gainetdinov, R. R., Nov 2020, In: European Neuropsychopharmacology. 20, S1, p. S358 P.636.

    Research output: Contribution to journalMeeting Abstractpeer-review

  10. Novel 1-amidino-4-phenylpiperazines as potent agonists at human taar1 receptor: Rational design, synthesis, biological evaluation and molecular docking studies

    Francesconi, V., Cichero, E., Kanov, E. V., Laurini, E., Pricl, S., Gainetdinov, R. R. & Tonelli, M., Nov 2020, In: Pharmaceuticals. 13, 11, p. 1-26 26 p., 391.

    Research output: Contribution to journalArticlepeer-review

  11. Disturbances in exploratory behavior in dopamine transporter knockout rats during learning cognitive tasks

    Volnova, A. B., Kurzina, N. & Gainetdinov, R. R., Oct 2020, In: ЖУРНАЛ ЭВОЛЮЦИОННОЙ БИОХИМИИ И ФИЗИОЛОГИИ. 56, 7, p. 809

    Research output: Contribution to journalMeeting Abstractpeer-review

Previous 1 2 3 4 5 6 7 8 ...10 Next

ID: 20160